Подкатегории
Active filters
Dyuralan is designed to restore joint mobility and relieve pain in them.
Lindron is indicated for the treatment of osteoporosis in postmenopausal women.
Dosage and route of administration
The recommended dose for treating osteoporosis is 1 tablet (10 mg) per day. To achieve maximum effect, it is very important to take pills in the morning at least 30 minutes before the first meal, drink or medicine during the day.
Lindron is indicated for the treatment of osteoporosis in postmenopausal women.
Dosage and route of administration
The recommended dose for treating osteoporosis is 1 tablet (10 mg) per day. To achieve maximum effect, it is very important to take pills in the morning at least 30 minutes before the first meal, drink or medicine during the day.
Dexofen® 25 mg. It is a painkiller from a group of drugs called non-steroidal anti-inflammatory drugs (NSAIDs). Dexofen® 25 mg is used to treat mild to moderate pain, such as muscle pain, dysmenorrhea and toothache.
If after 3-4 days you do not feel relief or your condition worsens, you should consult a doctor.
The drug Diamax for the symptomatic treatment of osteoarthritis, osteoarthrosis.
This drug belongs to the pharmacological group of muscle relaxants. It is used for the prevention and treatment of malignant hyperthermia, which can occur after general anesthesia and surgical interventions. In addition, Dantrolene is used in the fight against spastic muscle contractions in cases of spinal cord injuries, muscle inflammation, multiple sclerosis, etc.
treatment of frequent acute attacks of gouty arthritis and prevention of new attacks with inefficiency, intolerance or if there are contraindications to the use of NSAIDs and / or colchicine and if it is impossible to conduct therapy with repeated courses of corticosteroids;
This medication contains the active ingredient infliximab. Infliximab is a type of protein that contains parts of a person and a mouse.
The U.S. Food and Drug Administration (FDA) approved a 5 mg twice daily dose of XELJANZ® (tofacitinib citrate) for the treatment of moderate to severe active rheumatoid arthritis in adult patients with an inadequate response to methotrexate or its intolerance.
diseases of the musculoskeletal system (rheumatoid arthritis, psoriatic, juvenile chronic arthritis, ankylosing spondylitis; gouty arthritis, rheumatism of soft tissues, osteoarthritis of the peripheral joints and spine, including with radicular syndrome, tendovaginitis, bursitis);
Kevzara (Kevzara, sarilumab) is a new drug for the treatment of adult patients suffering from moderate to severe rheumatoid arthritis in the active phase, not adequately responding to or intolerant to one (or more) antirheumatic drugs that change the course of the disease (for example, methotrexate).
Kevzara (Kevzara, sarilumab) is a new drug for the treatment of adult patients suffering from moderate to severe rheumatoid arthritis in the active phase, not adequately responding to or intolerant to one (or more) antirheumatic drugs that change the course of the disease (for example, methotrexate).